Current pharmacotherapeutic options for primary dyslipidemia in adults
Sign Up to like & getrecommendations! Published in 2019 at "Expert Opinion on Pharmacotherapy"
DOI: 10.1080/14656566.2019.1604687
Abstract: ABSTRACT Introduction: Atherosclerotic cardiovascular disease (ASCVD) and its clinical manifestations, remain a leading cause of death and disability worldwide. One of the major risk factors of ASCVD is dyslipidemia and all the available guidelines suggest… read more here.
Keywords: primary dyslipidemia; current pharmacotherapeutic; treatment; pharmacotherapeutic options ... See more keywords
Pharmacotherapeutic Options for Chronic Refractory Cough.
Sign Up to like & getrecommendations! Published in 2020 at "Expert opinion on pharmacotherapy"
DOI: 10.1080/14656566.2020.1751816
Abstract: Introduction: Chronic refractory cough (CRC) is more than a persistent cough, but can cause serious impairment to quality of life. Through remarkable advances in our understanding of the neurobiology of cough, there is realization that… read more here.
Keywords: refractory cough; cough reflex; pharmacotherapeutic options; cough ... See more keywords
A pharmacoeconomic evaluation of the pharmacotherapeutic options for painful diabetic neuropathy
Sign Up to like & getrecommendations! Published in 2022 at "Expert Opinion on Pharmacotherapy"
DOI: 10.1080/14656566.2022.2032647
Abstract: ABSTRACT Introduction Painful diabetic neuropathy (PDN) is a high incidence and severe complication of diabetes mellitus, significantly compromising patients’ quality of life and causing tremendous economic burden. Considering drug costs becomes part of treatment decisions,… read more here.
Keywords: pharmacotherapeutic options; evaluation pharmacotherapeutic; diabetic neuropathy; treatment ... See more keywords
An up-to-date overview of the pharmacotherapeutic options for premature ejaculation
Sign Up to like & getrecommendations! Published in 2022 at "Expert Opinion on Pharmacotherapy"
DOI: 10.1080/14656566.2022.2035361
Abstract: ABSTRACT Introduction Premature ejaculation (PE) is a sexual dysfunction of unknown etiology affecting a substantial number of males and deteriorating sexual health and quality of life of the patient and his partner. Treatment still remains… read more here.
Keywords: overview pharmacotherapeutic; options premature; ejaculation; pharmacotherapeutic options ... See more keywords
An evaluation of the pharmacotherapeutic options for the treatment of adult phimosis. A systematic review of the evidence
Sign Up to like & getrecommendations! Published in 2022 at "Expert Opinion on Pharmacotherapy"
DOI: 10.1080/14656566.2022.2075697
Abstract: ABSTRACT Introduction Topical pharmacotherapy is often practiced in the treatment of adults with phimosis or Lichen Sclerosus (LS). However, it is unclear if it is effective. Areas covered The authors review pharmacological treatments in adults… read more here.
Keywords: expert opinion; evaluation pharmacotherapeutic; pharmacotherapeutic options; options treatment ... See more keywords
Pharmacotherapeutic options for pancreatic ductal adenocarcinoma
Sign Up to like & getrecommendations! Published in 2022 at "Expert Opinion on Pharmacotherapy"
DOI: 10.1080/14656566.2022.2149322
Abstract: ABSTRACT Introduction Pancreatic ductal adenocarcinoma (PDAC) is a lethal malignancy projected to be the 2nd leading cause of cancer related death in the USA by 2030. This manuscript discusses current and evolving treatment approaches in… read more here.
Keywords: pharmacotherapeutic options; ductal adenocarcinoma; gemcitabine; pancreatic ductal ... See more keywords
Pharmacotherapeutic options for cancer cachexia: emerging drugs and recent approvals
Sign Up to like & getrecommendations! Published in 2023 at "Expert Opinion on Pharmacotherapy"
DOI: 10.1080/14656566.2023.2209316
Abstract: ABSTRACT Introduction Cachexia is a complex multi-factorial syndrome characterized by anorexia, inflammation, body, and skeletal muscle wasting. Early diagnosis and intervention via a multimodal approach combining nutritional counseling, exercise, and pharmacological agents is advisable. However,… read more here.
Keywords: pharmacotherapeutic options; options cancer; emerging drugs; cancer cachexia ... See more keywords
The pharmacotherapeutic options in patients with catecholamine-resistant vasodilatory shock
Sign Up to like & getrecommendations! Published in 2022 at "Expert Review of Clinical Pharmacology"
DOI: 10.1080/17512433.2022.2110067
Abstract: ABSTRACT Introduction Septic and vasoplegic shock are common types of vasodilatory shock (VS) with high mortality. After fluid resuscitation and the use of catecholamine-mediated vasopressors (CMV), vasopressin, angiotensin II, methylene blue (MB), and hydroxocobalamin can… read more here.
Keywords: pharmacotherapeutic options; options patients; catecholamine resistant; vasodilatory shock ... See more keywords